Targeted binding of PLA microparticles with lipid-PEG-tethered ligands

Biomaterials

Volumn 28, Issue 33, 2007, Pages 4991-4999

  Duncanson, Wynter J ^a   Figa, Michael A ^a   Hallock, Kevin ^b   Zalipsky, Samuel ^c   Hamilton, James A ^a,b   Wong, Joyce Y ^a  

^a Boston University   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c ALZA CORPORATION   (United States)

Author keywords

Drug delivery; Lipid; Microsphere; Poly(lactic acid); Surface modification

Indexed keywords

DRUG DELIVERY; LIGANDS; LIPIDS; MICROSPHERES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE ANALYSIS; POLYETHYLENE GLYCOLS; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE;

FIELD-EMISSION SCANNING ELECTRON MICROSCOPY; PLA MICROPARTICLES; POLY(LACTIC ACID); TARGETED BINDING;

LACTIC ACID;

BIOTIN; LIPID; MACROGOL; POLYLACTIC ACID; THIOCTIC ACID;

ADSORPTION; ARTICLE; BINDING AFFINITY; DRUG DELIVERY SYSTEM; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY;

BIOCOMPATIBLE MATERIALS; BIOTIN; DRUG DELIVERY SYSTEMS; LACTIC ACID; LIGANDS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSPHERES; OILS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; PROTEIN BINDING; SURFACE PROPERTIES; THIOCTIC ACID; WATER;

EID: 34548461265     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.05.044     Document Type: Article

References (51)

1. Sakhalkar H.S., Dalal M.K., Salem A.K., Ansari R., Fu J., Kiani M.F., et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci USA 100 26 (2003) 15895-15900
2. Pfeifer B.A., Burdick J.A., and Langer R. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials 26 2 (2005) 117-124
3. Ermak T.H., and Giannasca P.J. Microparticle targeting to M cells. Adv Drug Deliv Rev 34 2-3 (1998) 261-283
4. Moshfeghi A.A., and Peyman G.A. Micro- and nanoparticulates. Adv Drug Deliv Rev 57 14 (2005) 2047-2052
5. Mordon S., Sumian C., and Devoisselle J.M. Site-specific methylene blue delivery to pilosebaceous structures using highly porous nylon microspheres: an experimental evaluation. Lasers Surg Med 33 2 (2003) 119-125
6. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 5665 (2004) 1818-1822
7. Keegan M.E., Falcone J.L., Leung T.C., and Saltzman W.M. Biodegradable microspheres with enhanced capacity for covalently bound surface ligands. Macromolecules 37 (2004) 9779-9784
8. Gref R., Couvreur P., Barratt G., and Mysiakine E. Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24 24 (2003) 4529-4537
9. Nobs L., Buchegger F., Gurny R., and Allemann E. Poly(lactic acid) nanoparticles labeled with biologically active neutravidin for active targeting. Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik e.V. 58 3 (2004) 483-490
10. Csaba N., Gonzalez L., Sanchez A., and Alonso M.J. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J Biomater Sci Polym Ed 15 9 (2004) 1137-1151
11. Saxena V., Sadoqi M., and Shao J. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int J Pharm 278 2 (2004) 293-301
12. Venier-Julienne M.C., and Benoit J.P. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm Acta Helv 71 2 (1996) 121-128
13. El-Sherif D.M., and Wheatley M.A. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A 66 2 (2003) 347-355
14. Belbella A., Vauthier C., Fessi H., Devissaguet J.-P., and Puisieux F. In vitro degradation of nanospheres from poly(d,l-lactides) of different molecular weights and polydispersities. Int J Pharm 129 1-2 (1996) 95-102
15. Illum L., and Davis S.S. The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett 167 1 (1984) 79-82
16. Fahmy T.M., Samstein R.M., Harness C.C., and Mark Saltzman W. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26 28 (2005) 5727-5736
17. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., et al. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10 2 (1999) 289-298
18. Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., and Zalipsky S. Direct measurement of a tethered ligand-receptor interaction potential. Science 275 5301 (1997) 820-822
19. Dong Y., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 14 (2004) 2843-2849
20. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B Biointerfaces 18 3-4 (2000) 301-313
21. Kim S.Y., Shin I.G., and Lee Y.M. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and dl-lactide block copolymer as novel drug carriers. J Controlled Release: Off J Controlled Release Soc 56 1-3 (1998) 197-208
22. Csaba N., Gonzalez L., Sanchez A., and Alonso M.J. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J Biomater Sci. Polyr Ed 15 9 (2004) 1137-1151
23. Ruan G., and Feng S.S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24 27 (2003) 5037-5044
24. Gunatillake P., Mayadunne R., and Adhikari R. Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 12 (2006) 301-347
25. Gabizon A., Shmeeda H., Horowitz A.T., and Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56 8 (2004) 1177-1192
26. Jeppesen C., Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., Zalipsky S., et al. Impact of polymer tether length on multiple ligand-receptor bond formation. Science 293 5529 (2001) 465-468
27. DeFrees S.A., Phillips L.M., Guo L.S.S., and Zalipsky S. Sialyl lewis X liposomes as a multivalent ligand and inhibitor of E-selectin mediated cellular adhesion. J Am Chem Soc 118 (1996) 6101-6104
28. Zalipsky S., Mullah N., Dibble A., and Flaherty T. New chemoenzymatic approach to glyco-lipopolymers: Practical preparation of functionally active galactose-poly(ethylene glycol)-distearoylphosphatididic acid (Gal-PEG-DSPA) conjugate. Chem Commun 7 (1999) 653-654
29. Jolimaitre P., Poirier C., Richard A., Blanpain A., Delord B., Roux D., et al. Synthesis of versatile chemical tools toward a structure/properties relationships study onto targeting colloids. Eur J Med Chem (2006)
30. Deshpande D., Blezinger P., Pillai R., Duguid J., Freimark B., and Rolland A. Target specific optimization of cationic lipid-based systems for pulmonary gene therapy. Pharm Res 15 9 (1998) 1340-1347
31. Burridge K.A., Figa M.A., and Wong J.Y. Patterning adjacent supported lipid bilayers of desired composition to investigate receptor-ligand binding under shear flow. Langmuir 20 23 (2004) 10252-10259
32. Farokhzad O.C., Khademhosseini A., Jon S., Hermmann A., Cheng J., Chin C., et al. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem 77 17 (2005) 5453-5459
33. Eniola A.O., and Hammer D.A. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity. Biomaterials 26 6 (2005) 661-670
34. Zalipsky S., Mullah N., and Qazen M. Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremities of polymer chains. Meth Enzymol 387 (2004) 50-69
35. Zalipsky S., Brandeis E., Newman M.S., and Woodle M.C. Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett 353 1 (1994) 71-74
36. Hrkach J.S., Peracchia M.T., Domb A., Lotan N., and Langer R. Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials 18 1 (1997) 27-30
37. Working PK, Newman MS, Johnson J, Cornacoff JB. Safety of PEG and PEG derivatives. In: Harris JM, Zalipsky S, editors. Poly(ethylene Glycol): chemistry and biological applications. Washington, DC: ACS Symposium Series; 1997. p. 45-57.
38. Gref R., Miralles G., and Dellacherie E. Polyoxyethylene-coated nanospheres: effect of coating on zeta potential and phagocytosis. Polym Int 48 4 (1999) 251-256
39. Gref R., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., and Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. AdvDrug Del Rev 16 2-3 (1995) 215-233
40. Tobio M., Gref R., Sanchez A., Langer R., and Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res 15 2 (1998) 270-275
41. Hawley A.E., Illum L., and Davis S.S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res 14 5 (1997) 657-661
42. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82 1 (2002) 105-114
43. Vila A., Gill H., McCallion O., and Alonso M.J. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 98 2 (2004) 231-244
44. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M., et al. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84 4 (1995) 493-498
45. Kuhl T.L., Leckband D.E., Lasic D.D., and Israelachvili J.N. Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys J 66 5 (1994) 1479-1488
46. Marques C.M., and Joanny J.F. Block copolymer adsorption in a nonselective solvent. Macromolecules 22 3 (1989) 1454-1458
47. Longo G., and Szleifer I. Ligand-receptor interactions in tethered polymer layers. Langmuir 21 24 (2005) 11342-11351
48. Chen C.C., and Dormidontova E.E. Architectural and structural optimization of the protective polymer layer for enhanced targeting. Langmuir 21 12 (2005) 5605-5615
49. Stibenz D., Grafe M., Debus N., Hasbach M., Bahr I., Graf K., et al. Binding of human serum amyloid P componentto l-selectin. Eur J Immunol 36 2 (2006) 446-456
50. Swers J.S., Widom A., Phan U., Springer T.A., and Wittrup K.D. A high affinity human antibody antagonist of P-selectin mediated rolling. Biochem Biophys Res Commun 350 3 (2006) 508-513
51. Whitmore R.L. Rheology of the circulation (1968), Pergamon Press, Oxford